My guest this week is Ian Keldoulis, co-author of Unblinded: The Startup That Launched a Revolution in Saving Sight. He wrote the book with Dr. David Guyer, chronicling the founding of Eyetech Pharmaceuticals in 2000. They developed Macugen, the first effective treatment for age-related macular degeneration (AMD), a disease that once blinded millions in their later years.

• Unblinded on Amazon
• Unblinded on Barnes & Noble
• Unblinded on the publisher's storefront

Blog post available at: https://www.sharesforbeginners.com/blog/ian-keldoulis

Watch on YouTube right here.

📈 CHECK OUT THESE INVESTING TOOLS:

🌎 Level up your investing with Sharesight, Investopedia’s #1 portfolio tracker for DIY investors. Click here to save 4 months on an annual paid plan

🌎 Life Sherpa Invest helps beginners start with confidence. Invest hassle-free now

🌎 When you’re ready to go beyond ETFs, learn from the master - Tony Kynaston’s QUALITY AT VALUE. Sign up with code SFB for a 20% discount on QAV Club plan or SFBLIGHT for a free month of QAV Light

🌎 Tykr - Stock Investing for Beginners. Learn how to avoid emotional mistakes, choose investments with a rationale, and build wealth with confidence. Visit https://www.sharesforbeginners.com/tykr or https://tykr.com/?red=finpod to start now.

Disclosure: The links provided are affiliate links. I will be paid a commission if you use this link to make a purchase. You will receive a discount by using these links/coupon codes. I only recommend products and services that I use and trust myself or where I have interviewed and/or met the founders and have assured myself that they’re offering something of value.

Hosted on Acast. See acast.com/privacy for more information.